This site is intended for healthcare professionals only
LoginRegister

Nephrology Dialogues

CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial

Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billion

Transaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a future regulatory...
View All

Latest News and Guidelines

Weekly Home BP Monitoring Enhances Hypertension Detection in Hemodialysis Patients: Study Finds

Weekly Home BP Monitoring Enhances Hypertension Detection in Hemodialysis Patients: Study Finds

Twice-Weekly and Thrice-Weekly Hemodialysis have Comparative Survival Outcomes: Study

Twice-Weekly and Thrice-Weekly Hemodialysis have Comparative Survival Outcomes: Study

Increased risk of acute kidney injury associated with chronic obstructive pulmonary disease: Study

Increased risk of acute kidney injury associated with chronic obstructive pulmonary disease: Study

Impaired Thyroid Hormone Sensitivity Linked to Increased Diabetic Nephropathy Risk in Euthyroid T2DM Patients: Study

Impaired Thyroid Hormone Sensitivity Linked to Increased Diabetic Nephropathy Risk in Euthyroid T2DM...

Serum midkine, Reliable Biomarker for Early Detection of Atherosclerosis in Non-Dialysis CKD: Study

Serum midkine, Reliable Biomarker for Early Detection of Atherosclerosis in Non-Dialysis CKD: Study

Glucosamine Use Linked to Lower Risk of Diabetic Nephropathy: Study

Glucosamine Use Linked to Lower Risk of Diabetic Nephropathy: Study

View All
X